Major limb replantation: Current status and perspectives

肢体再植:现状与展望

阅读:1

Abstract

BACKGROUND: Major limb replantation is a demanding microsurgical procedure aiming to restore form and function after traumatic amputation. Although survival has improved since the 1960s, ischemia, infection, and complex reconstruction continue to limit outcomes. Emerging preservation and reconstructive strategies may help expand indications and improve results. METHODS: For this scoping review, MEDLINE, Embase, and the Cochrane Library were searched from inception through December 2024 using predefined MeSH terms related to major limb replantation. Adult case series and reports were included; pediatric cases and long-term follow-up studies were excluded. Screening and data extraction were conducted independently by three reviewers, with consensus resolution of discrepancies. RESULTS: Ninety-nine publications reported outcomes in 1107 patients with traumatic amputations. The mean age was 31.6 years (range 17–63). Upper-limb replantation represented 88% of cases, most commonly at the forearm and elbow. Mean cold ischemia time was 10 ± 8 h and mean warm ischemia time 4.4 ± 2.3 h. Static cold storage was predominant (72%), while ex vivo dynamic perfusion and ectopic replantation were selectively applied. Overall replantation success was 68%, highest after sharp amputations (85%) and lower following crush (45%) and avulsion (55%) injuries. Vascular complications, infection, and systemic inflammatory response accounted for most failures. CONCLUSIONS: Major limb replantation remains constrained by ischemia-reperfusion injury and surgical complexity. New preservation techniques, adjunctive microsurgery, and optimized perioperative care show potential to improve viability and function. Continued multidisciplinary advancement is essential to strengthen outcomes and accessibility in both civilian and military trauma care.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。